Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding GB:BIOT?
Track your performance easily
GB:BIOT Price & Analysis
BIOT ETF Chart & Stats
Day’s Range― - ―
52-Week Range$9.04 - $11.26
Previous Close$9.99
VolumeN/A
Average Volume (3M)988.00
AUM17.89M
NAV9.98
Expense Ratio0.49%
Holdings Count38
Beta0.81
Inception DateJan 23, 2018
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard Deviation0.05
10 Day Avg. Volume3,544
30 Day Avg. Volume988
Alpha-0.00035
L&G Pharma Breakthrough UCITS ETF (BIOT) Fund Flow Chart
L&G Pharma Breakthrough UCITS ETF (BIOT) 1 year Net Flows: -$9M
BIOT ETF News
BIOT ETF FAQ
What was GB:BIOT’s price range in the past 12 months?
GB:BIOT lowest ETF price was $9.04 and its highest was $11.26 in the past 12 months.
What is the AUM of GB:BIOT?
As of Dec 20, 2024 The AUM of GB:BIOT is 17.89M.
Is GB:BIOT overvalued?
According to Wall Street analysts GB:BIOT’s price is currently Undervalued.
Does GB:BIOT pay dividends?
GB:BIOT does not currently pay dividends.
How many shares outstanding does GB:BIOT have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:BIOT?
Currently, no hedge funds are holding shares in GB:BIOT
BIOT ETF Smart Score
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Pharma Mar SA
5.22%
Xeris Pharmaceuticals
4.03%
Bristol-Myers Squibb Company
3.41%
Argenx
3.34%
InnoCare Pharma Ltd.
3.33%
Jazz Pharmaceuticals
3.33%
Ligand Pharmaceuticals Inc
3.29%
Nippon Shinyaku Co., Ltd.
3.15%
Catalyst Pharmaceutical Partners
3.15%
Supernus Pharmaceuticals
3.03%
Total35.27%
ETF Description
L&G Pharma Breakthrough UCITS ETF
The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.